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A systematic study of the dissociation patterns of crosslinked peptides analyzed by tandem
mass spectrometry is reported. A series of 11-mer peptides was designed around either a
polyalanine or polyglycine scaffold with arginine at the C terminus. One or two lysine residues
were included at various locations within the peptides to effect inter- or intra-molecular
crosslinking, respectively. Crosslinked species were generated with four commonly used
amine-specific chemical crosslinking reagents: disuccinimidyl suberate (DSS), disuccinimidyl
tartarate (DST), dithiobis(succinimidylpropionate) (DSP), and disuccinimidyl glutarate (DSG).
The influence of precursor charge state, location of crosslink, and specific crosslinking reagent
on the MS/MS dissociation pattern was examined. Observed trends in the dissociation
patterns obtained for these species will allow for improvements to software used in the
automated interpretation of crosslinked peptide MS/MS data. (J Am Soc Mass Spectrom
2006, 17, 395–405) © 2006 American Society for Mass SpectrometryChemical crosslinking has been demonstrated tobe an important tool for probing protein struc-ture, particularly where a crystal structure is not
yet available [1–7]. Crosslinking chemistry also is used
in the analysis of protein complexes, where it has been
applied to identify binding partners [8 –15], characterize
the interface of interacting subunits [16 –20], and stabi-
lize transient interactions [21, 22]. There are several
possible experimental approaches, many of which rely
on specifically identifying and characterizing the
crosslinked species by mass spectrometry. Both LCMS
and LCMS/MS have been used. A current challenge for
MS/MS studies is that little data exists to aid interpre-
tation of crosslinked peptide MS/MS, unlike the wealth
of data available for model peptide MS/MS.
To improve the methodology, work has been done to
more closely scrutinize the specificity of crosslinker
reactivity [23, 24], develop software for data analysis
[25–28], and develop and test crosslinkers with certain
properties such as affinity tags for product purification
or stable isotope labels [29 –34]. Interpretation of the
peptide sequences from a crosslinked species still re-
mains a challenge, however. Much “unexpected reac-
tivity” has been found, thus MS/MS confirmation can
be important.
Although much fundamental research has been done
on gas-phase dissociation of protonated and cationized
peptides [35– 40], only limited MS/MS studies have
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Given that the ability to determine crosslinked peptide
sequence is a key component of many experimental
approaches incorporating chemical crosslinking, it
would be of great advantage to know more about how
the crosslinked peptides dissociate in MS/MS so that
database search methods and de novo analysis can be
optimized for these spectra.
In this manuscript we report initial findings of
ongoing work to systematically study the dissociation
patterns of crosslinked peptides. In the current study
we report results on the influence of precursor charge
state, location of crosslink, and specific crosslinker used
for inter and intra molecularly crosslinked Lys–Lys
species.
Experimental
Materials
Peptides were custom synthesized by SynPep (Dublin,
CA) each with a blocked amino terminus (N-acetyl) and
provided at 98% purity as determined by HPLC. The
crosslinkers disuccinimidyl suberate (DSS), disuccin-
imidyl tartarate (DST), dithiobis(succinimidylpropi-
onate) (DSP), and disuccinimidyl glutarate (DSG) were
purchased from Pierce (Rockford, IL). Triethylamine
(TEA) was purchased from FisherBiotech (Fair Lawn,
NJ). Milli-Q deionized water was used. Methanol and
dimethyl sulfoxide (DMSO) were purchased from Bur-
dick and Jackson (Muskegon, MI). Formic acid was
purchased from EM Science (Darmstadt, Germany).
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Stock solutions (10 mg/mL) of each peptide and
crosslinker were prepared in water and DMSO, respec-
tively. The crosslinker stock solution was always freshly
prepared. Reactions were prepared by allowing 200
nmol total peptide to react with 200 nmol total
crosslinker. Total reaction volume was 50 L in 50 mM
TEA/carbonate buffer, pH 8.4. Reactions were incu-
bated at RT for 30 min, and stored at 4 °C until MS
analysis. Peptides and crosslinkers used in these reac-
tions are shown in Figures 1 and 2.
Mass Spectrometry
Samples were prepared for mass spectrometry by dilut-
ing 1 L of a given reaction to 1000 L in 50% aqueous
1 Ac-AAKAAAAAAAR
2 Ac-AAAAKAAAAAR
3 Ac-AAAAAAAAKAR
4 Ac-GGGGKGGGGGR
5 Ac-AAAAKAKAAAR
6 Ac-AAKAAAAAKAR
Figure 1. Custom synthesized peptides used in crosslinking
experiments.
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OFigure 2. Commercially available crosslinkers used.methanol containing 0.1% formic acid. For MALDI TOF
analysis, 1 L of diluted sample was mixed 1:1 with
-cyano-4-hydroxy-cinnamic acid (Agilent, Palo Alto,
CA) using the dried droplet method. Spectra were
acquired on an Applied Biosystems Voyager DE PRO in
positive reflectron mode, and close external calibration
was used. For ESI MS, diluted samples were directly
infused at 2 L/min into a Micromass QTOF running
Masslynx 4.0. Spectra were acquired in positive ion
“v”-mode. Collision energy was tuned to deplete the
precursor ion to 5% of the original isolated intensity.
Spectra were also acquired using identical collision
energies for each series of isomeric precursor ions for
comparison. Spectra were deconvoluted using the Max-
Ent3 algorithm provided with the Masslynx software.
Results and Discussion
Experimental Design and Crosslinked Products
The goal of this study was to systematically and specif-
ically probe the influence of crosslinker identity and
position on dissociation of crosslinked peptides in the
absence of other factors such as amino acid composi-
tion. Thus, a series of peptides designed around either a
polyalanine or polyglycine scaffold was synthesized as
shown in Figure 1. However, to incorporate two “real
world” features into the study, each peptide contained
11 total amino acids with arginine (Arg, R) at the C
terminus to approximate the average size and C-
terminal characteristic of peptides produced from a
tryptic digest, a common enzymatic digest protocol.
One or two lysine (Lys, K) residues were included at
various locations within the peptide to effect inter- or
intra-molecular crosslinking, respectively. The N termi-
nus of each peptide was blocked by acetylation so that
only the desired Lys–Lys crosslinks would be pro-
duced. The four chemical crosslinking reagents used in
this study are shown in Figure 2 and the reaction is
diagramed in Scheme 1.
Several different products arise from the reaction
between a chemical crosslinking reagent and a peptide/
protein. Nomenclature for these product types has
already been described [25] and will be used here.
Briefly, an intramolecular crosslink is termed Type 1,
while an intermolecular crosslink is termed Type 2. The
peptides within the Type 2 crosslink are differentiated
by  and  with the  chain having the longer chain
length or greater mass. A common side reaction prod-
uct observed when working with homobifunctional
N
O
O
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N
H
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O
NH2R1 +
Scheme 1NHS ester crosslinkers is a dead-end crosslink where
397J Am Soc Mass Spectrom 2006, 17, 395–405 CROSSLINKED PEPTIDE DISSOCIATIONonly one amide bond has been formed between a
peptide and one end of the crosslinking reagent. The
other NHS ester moiety has undergone hydrolysis and
is no longer reactive. This hydrolysis reaction is out-
lined in Scheme 2. These deadend “crosslinked” prod-
ucts have been termed Type 0.
The products formed in each of the reactions exam-
ined here were initially screened by MALDI TOF.
Spectra from the crude reaction mixtures of peptides 2
and 4 with DSS and of peptide 5 with DSS are shown in
Supplementary Material Figure 1a and b, respectively
(which can be found in the electronic version of this
article). The products observed are representative of the
reactions carried out with peptides 1–4 to generate Type
2 products (Supplementary Material Figure 1a) and
with peptides 5 and 6 to generate Type 1 products
(Supplementary Material Figure 1b). In both cases
shown here, some starting material remains (m/z 984.5,
77% relative abundance and m/z 858.4, 64% RA for
peptides 2 and 4 reaction; m/z 1041.7, 76% RA for
peptide 5 reaction). The relative abundance of starting
material in the final reaction mixture was a function of
the specific peptide and crosslinker, and in some cases
none was observed. The three expected Type 2 products
were observed in Supplementary Material Figure 1a,
namely, 2/2 (m/z 2106.2, 17% RA), 2/4 (m/z 1980.0,
100% RA), and 4/4 (m/z 1853.9, 47% RA) crosslinked
with DSS. Type 0 products were observed for both 2
(m/z 1140.6, 48% RA) and 4 (m/z 1014.5, 29% RA) as well.
Products of the reaction between 5 and DSS (Supple-
mentary Material Figure 1b) included Type 1 and Type
0 crosslinked 5 (m/z 1179.8, 100% RA and m/z 1197.8, 5%
RA). In addition to the expected Type 0, 1, and 2
crosslinked products there were several unexpected
species. For example, in Supplementary Material Figure
1a there are species 67 and 97 Da larger than the
expected Type 0 products for 4 (at m/z 1081.6, 57% RA
and m/z 1111.5, 9% RA) and for 2 (at m/z 1207.7, 26% RA
and m/z 1237.6, 12% RA). These additional products
were observed for reactions of DSS, DSG and DSP with
1–4 but not for analogous reactions using DST. Tandem
mass spectra of these unexpected products at 67 Da
and 97 Da does indicate that they are analogs of the
expected Type 0 products with the additional mass
(67 Da, 97 Da) localized at the lysine residue (data
not shown). The calculated masses of the expected Type
0 products are based on the assumption that the NHS-
ester which does not form a peptide-crosslinker bond
will undergo rapid hydrolysis as shown in Scheme 2. If
this is not the case and the succinimidyl ester remains
N
O
O
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O
HO R
O
H2O +
Scheme 2intact, the Type 0 product formed will be observed at 97Da greater in mass. The origin of the 67 Da product is
currently unknown; however, given the nitrogen rule,
the odd mass shift indicates that the adduct likely
contains an odd number of nitrogens (i.e.; at least one).
Previous studies of reaction products of DSP revealed
impurities in the commercial crosslinker that lead to
side reaction products during chemical crosslinking
[23]. Possibly in a similar fashion there are amine
containing impurities in either the peptide or
crosslinker starting materials, which lead to an unex-
pected crosslink between the peptide and the contami-
nant. The fact that the adduct is likely to contain at least
one nitrogen, and that the adduct was observed local-
ized on the lysine, makes this conclusion plausible. This
is one possibility currently being explored. The obser-
vation of such abundant side reaction products high-
lights a potential pitfall when using chemical crosslink-
ers in protein structure determination. Namely, that
unpredicted modifications or reaction products can
severely complicate the interpretation of the MS spec-
tra. The chance of a false assignment based solely on
precursor m/z is increased, and MS/MS confirmation
becomes even more important.
For most reactions between the dilysine containing
peptides 5 and 6 with a given crosslinker a small
amount of high molecular weight product was ob-
served as shown in the Supplementary Material Figure
1b inset (m/z 2358.6, 0.5% RA, signal-to-noise of 16.7). In
each case, the mass of the observed product is consis-
tent with the type of structure shown in the figure. The
proposed structure represents a Type 2,2 product, two
peptides intermolecularly crosslinked in two locations.
Possibly, this species is actually a gas-phase adduct
between two Type 1 crosslinked products. However, for
the reactions of 5 and 6with DST, low abundant species
were also observed that would correspond to a Type 2
product (m/z 2196.3, a singly intermolecularly
crosslinked dimer) and a Type 2,0 product (m/z 2328.3,
a dimer containing one intermolecular crosslink and
one dead-end crosslink). These observations support
the proposed Type 2,2 structure.
Dissociation of Starting Material
The MS/MS for each starting material used to generate
Type 2 crosslinks are shown in Figure 3. The spectra
acquired at identical collision energy values (CE  15)
for the isomers 1, 2, and 3 were qualitatively similar to
spectra obtained by tuning the collision energy to
deplete each precursor to 5% of original intensity. The
most abundant product ion for peptides 1, 2, and 4
represent dissociation of the peptide bond C-terminal to
the lysine residue (i.e.; y8, y6, and y8, respectively) as
shown in Figure 3a, b, and d. Preferential cleavage at
Lys–Xxx has been previously observed [37]. Peptide 3
(Figure 3c) does not exhibit this cleavage preference,
however. The analogous product ion in the case is y2
which is observed at only 6% relative abundance. The
most abundant product ions for 3 are b3 (100% RA) and
398 GAUCHER ET AL. J Am Soc Mass Spectrom 2006, 17, 395–405y7 (78% RA), representing dissociation within the poly-
alanine portion of the molecule. This is most likely
observed because a charge driven dissociation to yield a
y2 product from the doubly protonated precursor
would require both protons to come in close proximity
to one another: one proton is expected to be “fixed” at
the C-terminal arginine, and a second proton promot-
ing dissociation at Lys2 would thus be only two resi-
dues away. Charge repulsion likely prevents this from
occurring and promotes greater delocalization of the
second proton which drives dissociation within the first
few residues of the peptide.
One unexpected observation was the influence of
alanine versus glycine on the dissociations observed as
seen by comparing products of 2 and 4 (Figure 3b and
d). In both cases the y6 product ion is the base peak in
MS/MS, but for the polyglycine peptide this is the only
product ion observed above 18% RA. Alanine is slightly
more electron donating than glycine, which may lead to
greater proton mobility within the polyalanine back-
bone and may explain why a greater abundance of
dissociation products generated within the polyalanine
sequence was observed.
Two peptides (5 and 6) each containing 2 Lys resi-
dues to promote Type 1 crosslinked products were
examined by MS/MS (Supplementary Material Figure
2, (see the electronic version of this article). Peptide 5
with Lys at positions 5 and 7 can be viewed as an analog
Figure 3. Tandemmass spectra of peptide starti
Type 2 products.of 2, while peptide 6 with Lys at positions 3 and 9 isanalogous to both 1 and 3. Interestingly, the MS/MS
dissociation observed for doubly charged precursor
ions of these di-lysine containing peptides 5 and 6 were
virtually identical to a monolysine analog, namely 2
and 1, respectively. These observations can be rational-
ized by considering the most likely sites of protonation
for doubly charged 5 and 6. In each case, the C-terminal
arginine will sequester one proton. Two basic sites on
each peptide then remain (the two lysine residues). The
second proton is more likely to reside on the lysine
furthest away from the protonated arginine due to
charge repulsion. Thus, for 5, this second proton is most
likely associated with Lys5, which makes the resulting
ionic species a direct analog of 2. For peptide 6 the
second proton is most likely associated with Lys3, an
analogous ion to doubly charged 1.
Dissociation of Type 2 Crosslinks: Influence
of Precursor Charge State
Type 2 (intermolecular crosslink) DSS crosslinked peptide
2 was examined by MS/MS in both 2 and 3 charge
states. Given that this species contains two basic residues
(arginine), the 2 and 3 charge states are expected to
contain zero and one mobile protons respectively. The
deconvoluted MS/MS for each of these species is shown
in Figure 4. The 2 precursor requires significantly more
aterial used in crosslinking reactions to generateng menergy for dissociation as compared to the 3 precursor
399J Am Soc Mass Spectrom 2006, 17, 395–405 CROSSLINKED PEPTIDE DISSOCIATION(50 V versus 12 V). In both cases the precursor ion was
depleted to 5% of the initial intensity. The product ions
observed for the 2 precursor are predominantly low
mass species. There are many unique products from the
2 precursor observed below 600 Da but these do not
represent a/b/y type dissociation products of use for
sequence determination. In the 600–1500 Da range the
most abundant product ions observed for the 2 precur-
sor were also present for the 3 precursor although at
different relative intensities. Interestingly, the products
observed above 1500 Da from the 2 precursor were
generated by a-type cleavages, rather than the b/y cleav-
ages observed from the 3 precursor. Overall, although
the 2 type 2 crosslinked species dissociates through
some unique pathways with respect to the 3 analog, it
provides fewer and less abundant ions of use for sequence
determination. This is similar to results found previously
for singly charged isolated peptides—species without a
mobile proton. Thus, only 3 ions were investigated in
the remaining experiments on Type 2 species.
Dissociation of Type 2 Crosslinks: Influence
of Crosslinker Identity
The dissociation pathways open to peptide 2 intermo-
lecularly crosslinked by either DSG, DST, DSS, or DSP
were examined to identify and catalogue observed
dissociation within the crosslinker moiety and to deter-
mine whether the specific crosslinker used had an
influence on the product ions observed. B- and y-type
cleavages within the peptides were observed for all four
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Figure 4. Deconvoluted tandem mass spectra o
deplete the precursor ion to 5% of the origin
collision energy of 50V. (b) 3 Precursor MS2 wprecursors examined, and the patterns (relative abun-dance) were qualitatively similar to that shown in
Figure 4b. Thus, for the crosslinkers and model peptide
used here, no appreciable difference based on
crosslinker identity was observed with respect to disso-
ciation within the peptide. However, product ions aris-
ing from cleavage within the crosslinker or apparently
promoted by the crosslinker were observed for all four
crosslinkers examined. The mass regions of interest for
these products are shown in Figure 5a for each product
ion spectrum. Deconvoluted spectra are shown for
clarity, and the mass regions are shown relative to each
other such that analogous dissociation products are
vertically aligned. Assignments for the observed disso-
ciations are pictured in Figure 5b and are discussed
below.
Products from two dissociation pathways internal to
the crosslinker were observed. The first involves cleav-
age within the amide bond formed between crosslinker
and lysine residue which was observed for all four
crosslinkers used in this study. This dissociation is
analogous to b- and y-type cleavage within the peptide
backbone and has been cited previously [25, 41]. Two
product ions may be formed as shown in Figure 5b
labeled as L5 and L13 according to previously pro-
posed nomenclature [25]. The former (L5) represents a
y-like dissociation and would appear at m/z 984.6 for
each of the four precursors examined because this
product ion essentially corresponds to peptide 2. How-
ever, this product could only definitively be observed
for DSG crosslinked 2 due to overlapping components
within this mass region for the DST, DSS, and DSP
mass
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400 GAUCHER ET AL. J Am Soc Mass Spectrom 2006, 17, 395–405(L13) results from a b-like dissociation and includes
the crosslinker moiety. DSG crosslinked 2 yielded the
highest abundance of this product relative to the other
precursors, which was observed at both m/z 1080.6
and m/z 540.82 in the original spectrum. The DST, DSS,
and DSP crosslinked precursors yielded a minor
amount of this b-like dissociation product at m/z
1098.5, m/z 1122.6, and m/z 1158.5, respectively. No
appreciable amount of the corresponding doubly
charged species were observed.
The second dissociation observed within a
crosslinker was unique to DSP and represented disso-
ciation of the disulfide bond present in this cross-
linker. As shown in Figure 5b, dissociation of the
SOS bond occurs with proton transfer to the result-
ing observed product ion, presumably forming a sulf-
hydryl moiety. This product is observed at m/z 1072.6
(Figure 5a).
In addition to dissociation within the crosslinker
moiety, the presence of a crosslinker in these Type 2
species appears to promote particular two-bond cleav-
ages within the peptide backbone. The first series of
products appears for DSG, DST, DSS, and DSP
crosslinked 2 at m/z 1180.69, 1198.65, 1222.72 and
1258.62, respectively, while the second series appears
17 Da lower in mass (Figure 5a). The dissociating bonds
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molecule.are directly adjacent to the site of crosslinking in eachcase as diagrammed in Figure 5b. The first series
essentially represents the formation of the lysine immo-
nium ion with the crosslinker and second peptide
“modification” still attached. Thus, we propose to an-
notate this product as KL where the subscripts L and 
represent “linker” and “ peptide”, respectively. The
second series is likely a loss of ammonia from the first
series. Interestingly, previous researchers annotated
similar dissociation pathways in crosslinked species
they examined although it was not the focus of their
investigation [34]. In addition, Schilling and coworkers
[25] observed an equivalent cleavage product for type 0
crosslinked species (KL  17) and proposed a mecha-
nism to account for the facile loss of ammonia. For the
DST crosslinked species examined in the present work,
the KL product was as abundant as KL  17. A small
amount of the KL product ion was observed for DSG,
DSS, and DSP crosslinked species but the correspond-
ing KL  17 product was observed at greater abun-
dance. Note that in this case, because the  and 
peptides are equivalent, these products could be anno-
tated equivalently as KL or KL. Ongoing work in
our laboratory [42] suggests that these KL/KL  prod-
uct ions are present even when the crosslinked pep-
tides contain amino acids such as aspartic acid, D,
known to itself promote dissociation of the peptide
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of Crosslink Location.
Dissociation patterns for Type 2 crosslinked polyala-
nine peptides were examined as a function of crosslink
location relative to the peptide C terminus. Triply
charged precursors for the DSS-crosslinked species of
peptides 1, 2, and 3 (homo-crosslinked products) were
examined. Collision energy for each precursor was 12V
which also served to deplete each precursor ion to 5% of
the original intensity. The primary difference among
the three spectra, shown in Supplementary Material
Figure 3, (which can be found in the electronic version
of this article.) was the charge state distribution of the
product ions formed. No (3% RA) 3 charged prod-
ucts were formed for DSS crosslinked 3 (Supplementary
Material Figure 3c), where the site of crosslinking was
located near the C terminus. For MS/MS of DSS
crosslinked 1 and 2 however (Supplementary Material
Figure 3a and b), the y ion series appeared as 3 species
in addition to the 2 species observed for all three
precursors. Similarly the KL  17 cleavage product ion
discussed above was observed in a 2 charge state at
m/z 603.32 for crosslinked 1 and 2 but only in a 1
charge state (m/z 1205.7) for crosslinked 3. In fact, this
product ion was observed only as a 2 ion for
crosslinked 1; no 1 charge state was observed for this
precursor, where the site of crosslinking was close to
the N-terminus.
The dissociation patterns of hetero-crosslinked spe-
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Figure 6. Tandem mass spectrum of the hetero
chain), (a) original MS2 data, (b) spectrum decocies were also examined as a function of crosslinklocation. Polyglycine peptide 4 was DSS-crosslinked
with one of the polyalanine peptides 1, 2, or 3 and the
resulting 3 species was allowed to undergo collision
induced dissociation such that each precursor ion was
depleted to 5% of the initial signal intensity. The type
and charge state distribution of the observed products
were qualitatively similar to the corresponding homo-
crosslinked products of 1, 2, and 3. Dissociation of the
peptide 4 moiety was minimal to absent in each hetero-
crosslinked species examined. Most interesting, there
was a distinct preference for dissociation within the
polyalanine peptide and not the polyglycine peptide
such that KL  17 (m/z 1079.6) and not KL  17 (m/z
1205.7) was observed preferentially.
TheMS/MS spectrum acquired for the 4/2 crosslinked
species is shown in Figure 6 (original and deconvoluted).
Comparison of the spectrum in Figure 6a and Supplemen-
tary Material Figure 3b is representative of the close
correspondence observed between the homo-crosslinked
and analogous hetero-crosslinked species. For example,
the relative abundance ratio of singly to doubly charged
KL  17 product is 1 in each case: 0.954 for the
hetero-crosslinked species and 1.016 for the homo-
crosslinked species. For the 4/3 crosslinked species (data
not shown) no (3% RA) 3 y ions were observed, and
KL  17 was only observed at m/z 1079.6 as a singly
charged species similar to the 3/3 crosslinked species. The
4/1 crosslinked species (data not shown, but similar to
1/1) yielded both 2 and 3 y ions as well as predomi-
m/z
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The NHS esters used for these crosslinking reactions
hydrolyze over time in the presence of water as shown
in Scheme 2. If hydrolysis of the remaining NHS ester
occurs after the first reacts with a primary amine on a
peptide, the intra or intermolecular crosslink can no
longer be formed. Thus, a common side reaction prod-
uct formed during chemical crosslinking with NHS
esters is the so called “dangling” crosslink, or Type 0
species. Type 0 species formed in the reactions between
peptide 1, 2, or 3 with DSS and in reactions between
peptide 2 with DSG, DST, and DSP were examined to
determine the similarities and differences in dissocia-
tion pathways observed as compared to analogous
starting material or Type 2 species.
The CID spectrum acquired for the DSS/2 Type 0
species generated in this study is shown in Figure 7. The
base peak in this spectrum arises from y6 cleavage,
similar to what is observed for the unmodified peptide
(see Figure 3). In contrast to the unmodified peptide,
however, the relative intensity of certain y ions, partic-
ularly y2, y3, and y4 are significantly increased in the
Type 0 species, and nearly the entire y ion series is
observed. In addition, the entire b ion series is observed
(b2–b10) for the Type 0 species, whereas only b2–b4 were
observed above 10% RA for the unmodified peptide 2.
The presence of nearly the entire series of b and y ion
products (b3–b10 and y2–y11) was similarly observed for
all Type 0 species examined. Thus, this observation was
independent of crosslinker type or position. The less
selective cleavage observed for the Type 0 species is
mostly likely because in the Type 0 species, the only
strongly basic site is the C-terminal arginine. Thus, for
these doubly charged Type 0 precursors, one proton is
sequestered at R and the second proton is relatively
freer to drive dissociation at any point along the re-
mainder of the peptide backbone than for the unmodi-
200 300 400 500 6
%
0
100
AAAAKAAAAAR
b112+
y6
M+H
y4
b4
y3b3
y2
b2
y1
y5
344.19
c4
y6
c4
y102+
y92+
y82+
y72+
KL
240.16
Figure 7. Tandem mass spectrum of thfied peptide containing an internal lysine. This is alsotypical of the product distribution for triply charged
Type 2 species examined in this study.
No products were observed to arise solely from the
Type 0 precursor of a given crosslinker (DSS, DSG, DST,
DSP). Products corresponding to the SOS bond disso-
ciation (expected at m/z 1072.6 or 107.0) for DSP were
not observed. Also, products corresponding to dissoci-
ation of the amide bond between crosslinker and pep-
tide were not observed. Products arising from the two
bond KL cleavage were observed for the Type 0 species
of DSG (m/z 198.11), DST (m/z 216.08), DSS (m/z 240.16),
and DSP (m/z 276.08). In addition, the product of single
bond dissociation at c4 is observed for the DSG, DST,
DSS, and DSP crosslinked peptide 2 at m/z 344.2. Note
that this represents dissociation of the bond immedi-
ately adjacent to the site of crosslinking. The c cleavage
is not observed for unmodified peptide 2 suggesting
that the presence of the crosslinker modification pro-
motes this dissociation process. The analogous c2 or c8
single bond dissociation products that might be ex-
pected from Type 0 modified 1 or 3 are not observed,
however.
Dissociation of Type 1 Crosslinks
The singly and doubly charged precursors for the Type
1 (intramolecular) crosslinked peptide 5 with DSS were
examined by MS/MS. In a manner similar to the Type
2 species examined, Type 1 peptides lacking a mobile
proton (1 species) required significantly more energy
for dissociation than the doubly charged precursor (65
versus 12 V, respectively). Additionally, the product
ions generated from the singly charged precursor are
relatively low molecular weight species with few b or y
ions useful for deducing sequence.
Tandem mass spectrometric dissociation of doubly
charged Type 1 crosslinked peptides were then exam-
m/z700 800 900 1000
MS2 m/z 570.82+
y10
b10
y9
b9
b8
y7
b6 y8
b7
e 0 species formed between DSS and 2.00
b5ined as a function of distance between the sites of
, y9/
403J Am Soc Mass Spectrom 2006, 17, 395–405 CROSSLINKED PEPTIDE DISSOCIATIONcrosslinking by comparing MS/MS of DSS crosslinked 5
(Figure 8a) versus 6 (Figure 8b). The tandem mass
spectra of Type 1 species are substantially more com-
plex than the Type 2 species examined, particularly as
the distance between the 2 sites of intra-molecular
crosslinking increases.
It is noteworthy that intramolecularly crosslinked
peptides may be viewed as cyclic peptide analogs. More
specifically, Type 1 crosslinked 5 and 6 are analogous to
species containing both cyclic and linear peptide moi-
eties. Based on previous tandem mass spectrometry
studies of cyclic peptides [43], it is therefore likely that
any of the peptide bonds between Ala4 and Ala8 in
Type 1 crosslinked 6 undergo a “ring opening” disso-
ciation. The resulting ion now has two additional ter-
mini from which dissociation of these amino acids may
occur. In the case of crosslinked 5 a ring opening
dissociation is restricted to the bonds on either side of
Ala6, and from there only one additional terminus is
formed, making the origin of observed products unam-
biguous. Because 6 is based on polyalanine, many of the
possible dissociation products would have identical m/z
values making them indistinguishable. For example, the
product ion labeled as originating from a y9/y8/a4
cleavage could also have arisen from y9/y7/a3. This
suggests that MS/MS of a more heterogeneous Type 1
crosslinked peptide, a subject of future studies, may be
much more complex. In that case, multiple stages of
mass spectrometry may be required to sequence such
200 300 400 500 600
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b
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175.1
214.1 285.2
MS2 m/z 590.32+
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y2y9
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y2
y1
Figure 8. (a) Deconvoluted tandem mass spect
tandem mass spectrum of Type 1 DSS crosslink
triangle, filled square, open circle, and open tria
from the “parent” structure (e.g.; M  H, b9, y9species as has been proposed for cyclic peptides [43].Thus, Type 1 crosslinked 5 has only a few additional
product ions in comparison to the unmodified starting
material. In particular, the products resulting from
b5/y5 and y7/y6/a6 multiple bond dissociations are
observed. As shown in Figure 8a, these products in-
volve the loss of Ala6 from the precursor ion. In
contrast, the MS/MS for Type 1 crosslinked 6 is very
complex due to so many additional product ions as
compared to both the unmodified peptide 6 and
crosslinked 5. This is illustrated in Figure 8b, where
successive losses of Alan from the precursor or in
conjunction with other dissociations (for example, y9 or
b9) are annotated with identical markers (e.g.; shaded
triangle, shaded square, open circle, and open triangle.)
Another prominent feature of these Type 1 precur-
sors is the y cleavages at each site of crosslinking are
greatly enhanced in comparison with that observed for
the unmodified starting material. Thus, cleavages at y4
and y7 are prominent in the MS/MS of Type 2
crosslinked 5, while those at y2 and y9 are prominent in
the MS/MS of 6. Type 1 species of DSG, DST and DSP
crosslinked 5 and 6 were also examined by MS/MS,
however, no differences in these spectra were observed
with respect to the DSS crosslinked analog.
Conclusions
Tandem mass spectra for Type 0, 1, and 2 crosslinked
species (dangling, intramolecular and intermolecular
mass800 900 1000 1100
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y9
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AAAR AAAAK KAAAR
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1005.6
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y9/y8/a4
b9
of Type 1 DSS crosslinked 5. (b) Deconvoluted
Each series of equivalent markings (e.g.; filled
indicates the loss of Alan (where n  1 up to 5)
y8/a4) within the Ala4–Ala8 sequence.700
676.40
K K
700
rum
ed 6.
ngle)crosslinks) were examined. A series of crosslinkers and
404 GAUCHER ET AL. J Am Soc Mass Spectrom 2006, 17, 395–405peptides was used to probe the effect of precursor
charge state, crosslinker identity and crosslink type/
location on the resulting product distribution. Similar to
unmodified peptides, precursor ions lacking a mobile
proton required more energy for dissociation and
yielded fewer ions for sequence determination than
precursors with a mobile proton. The specific
crosslinker used (DSG, DST, DSS or DSP) did not
promote differential cleavage within the peptide moiety
in the Type 0, 1, or 2 precursors examined. Dissociation
of the peptide bonds adjacent to the site of crosslinking
was enhanced, however, independent of the crosslinker
used. For Type 2 precursors, dissociation within the
crosslinker was also observed at the amide bond be-
tween peptide and crosslinker. One crosslinker-specific
dissociation product was observed corresponding to
SOS bond dissociation within the crosslinker DSP.
Crosslink location influenced the dissociation prod-
ucts observed in two ways. For the Type 2 precursors
examined, site of crosslinking influenced the charge
state of MS/MS products observed. Crosslinking near
the C-terminus yielded products in lower charges than
analogous products from precursors crosslinked near
the N-terminus. For the Type 1 precursors examined,
greater distance between the crosslinker sites of attach-
ment lead to a greater number of internal cleavage
products observed and, thus, more complex MS/MS
data.
Observed trends in the dissociation patterns ob-
tained for these species will allow for improvements to
software used in the automated interpretation of
crosslinked peptide MS/MS.
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